These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6192580)

  • 21. The role of prostate-specific antigen in the evaluation of benign prostatic hyperplasia.
    Tchetgen MB; Oesterling JE
    Urol Clin North Am; 1995 May; 22(2):333-44. PubMed ID: 7539179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer.
    Allen D; Butt A; Cahill D; Wheeler M; Popert R; Swaminathan R
    Ann N Y Acad Sci; 2004 Jun; 1022():76-80. PubMed ID: 15251943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic and prognostic significance of cytological malignancy grading of prostatic carcinoma].
    Faul P
    Urologe A; 1983 May; 22(3):127-33. PubMed ID: 6683896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytophotometric and automated cytodiagnosis].
    Böcking A
    Microsc Acta Suppl; 1983; 6():91-102. PubMed ID: 6578409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ploidy results in prostatic carcinoma vary with sampling method and with cytometric technique.
    Hardt NS; Hendricks JB; Sapi Z; Tykochinsky G; Wilkinson EJ; Epstein HB; Wajsman Z
    Mod Pathol; 1994 Jan; 7(1):44-8. PubMed ID: 8159651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.
    Hillenbrand M; Bastian M; Steiner M; Zingler C; Müller M; Wolff JM; Seiter H; Schuff-Werner P
    Anticancer Res; 2000; 20(6D):4995-6. PubMed ID: 11326656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The measurement of DNA in material obtained by cyto-puncture of the prostate. Diagnostic, prognostic and therapeutic value (author's transl)].
    Bouffioux C
    J Urol (Paris); 1982; 88(2):111-5. PubMed ID: 6178781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cancer of the prostate stage T1. Incidental carcinoma. Review of the literature and an appraisal of the classification].
    Leisinger HJ
    Ann Urol (Paris); 1994; 28(4):229-34. PubMed ID: 7979213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased discrimination between benign prostatic hyperplasia and prostate cancer through measurement of percentage free PSA.
    Wolff JM; Boeckmann W; Effert PJ; Habib FK; Jakse G
    Anticancer Res; 1997; 17(4B):2993-4. PubMed ID: 9329583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
    van der Kwast TH; Hoedemaeker RF; Schröder FH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transrectal prostate sonography in early cancer recognition].
    Frentzel-Beyme B; Aurich B; Drakopoulos A
    Computertomographie; 1983 Dec; 3(4):153-8. PubMed ID: 6199109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transrectal fine needle aspiration of prostate.
    Jayaram G; Nakra N; Verma AK; Goel GD
    J Assoc Physicians India; 1993 Jun; 41(6):364-6. PubMed ID: 7516326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
    Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
    BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Andersson L; Hagmar B; Ljung BM; Skoog L
    Scand J Urol Nephrol Suppl; 1994; 162():43-9; discussion 115-27. PubMed ID: 7817160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytology of prostatic carcinoma. Quantification and validation of diagnostic criteria.
    Böcking A; Auffermann W; Schwarz H; Bammert J; Dörrjer G; Vucicuja S
    Anal Quant Cytol; 1984 Jun; 6(2):74-88. PubMed ID: 6465698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomy.
    Romics I; Bocsi J; Bach D; Beutler W; Frang D; Kopper L
    Anticancer Res; 1995; 15(3):1131-4. PubMed ID: 7645937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.